Tag: Manufacturing

Displaying 1 - 20 of 194 results.

Pages

The number of reverse-payment patent settlements entered into by pharmaceutical companies in fiscal year 2015 declined from fiscal year 2014, marking a second annual decrease in such settlements, according to a new FTC staff report.
Moonlight Slumber, LLC, an Elgin, Illinois-based firm that advertised its baby mattresses as organic and free of volatile organic compounds (VOCs), has agreed to settle Federal Trade Commission charges that it misrepresented or could not support its claims to consumers. The case is the FTC’s first...
The Federal Trade Commission has closed its investigation of several agreements between Honeywell International, Inc. and E.I. DuPont de Nemours & Co.1 related to the sale of 1234yf, the next generation refrigerant in automotive air conditioning systems.
Following a public comment period, the Federal Trade Commission has approved a final order resolving concerns that the acquisition of the Valspar Corporation by The Sherwin-Williams Company would likely allow the new company to exercise unilateral market power in the North American market for...
In testimony presented to the U.S. House of Representatives’ Judiciary Committee Subcommittee on Regulatory Reform, Commerical and Antitrust Law, the Federal Trade Commission described its efforts to stop anticompetitive conduct in the pharmaceutical industry.
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business would (1) reduce current competition in the United States for the...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business is anticompetitive.According to a complaint filed by...
Following a public comment period, the Federal Trade Commission has approved an application from LaFargeHolcim, Ltd to amend several agreements that were part of a 2015 FTC order settling charges that the $25 billion merger of Holcim Ltd. and Lafarge S.A. would likely harm competition in the United...
The Federal Trade Commission has approved the appointment of Quantic Regulatory Services, LLC as monitor in its case alleging that Endo Pharmaceuticals Inc. violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm.
The Federal Trade Commission is currently accepting public comments on an application by Grifols, S.A., a manufacturer of plasma-derived drugs, to amend the terms of a manufacturing agreement that was part of a 2011 FTC-ordered divestiture.
The Federal Trade Commission is currently accepting public comments on an application by LafargeHolcim Ltd. to amend the terms of several agreements that were part of a 2015 FTC order settling charges that the $25 billion merger of Holcim and Lafarge would likely harm competition in the United...

Pages